Transferability and Reproducibility of the HepaRG CometChip Assay
Environmental and Molecular Mutagenesis · 2025
DOI: 10.1002/em.70037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental and Molecular Mutagenesis, 2025. Verfasst von Leslie Recio und 10 weiteren Autor:innen. Beteiligte Einrichtung: Integrated Laboratory Systems, Research Triangle Park, North Carolina, USA. Hauptthemen laut MEDLINE: Comet Assay, DNA Damage, Mutagens. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, SBIR 2B, Charles River Laboratories.
Abstract (Originalsprache)
This interlaboratory evaluation of HepaRG CometChip was conducted to assess transferability and reproducibility of this new approach methodology (NAM) across four laboratories. Concentrations inducing up to ~70% relative cytotoxicity were determined by the organizing laboratory, and frozen chemical formulation blocks were sent to each participant. When noncytotoxic, 10 mM was the maximum dose. Cultures were exposed once daily for three consecutive days, and both cytotoxicity assessment, via ATP quantification, and comet analysis, commenced 3–4 h after initiation of the final exposure. Positive response was statistical pairwise significance ( p < 0.05) with concentration‐related increases in %Tail DNA across ≥ 2 consecutive exposures. For 8 of 11 compounds, all four labs generated unanimous test results, with four negative compounds (2‐acetylaminofluorene [2‐AAF], 2,4‐dichlorophenol, eugenol and hydroquinone) and four positive compounds (azidothymidine, benzo(a)pyrene [BP], cyclophosphamide [CP], ethyl methanesulfonate).For the remaining chemicals, three of four labs generated negative calls for amitrole, cadmium chloride, and DMBA. In cases where bulky lesions were anticipated, the magnitude of %Tail DNA was low, due to the inherent insensitivity of the alkaline comet assay (not the CometChip per se) to detect bulky adducts repaired by nucleotide excision repair. This is supported by the small magnitude in %Tail DNA induced by BP and CP. Taken together, for all compounds there was majority agreement in CometChip results across participating laboratories supporting that the endpoint is readily transferable to new labs. Overall, this platform is a promising human‐relevant NAM, with a physiologically relevant detoxification process that could be incorporated into rodent replacement strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Integrated Laboratory Systems, Research Triangle Park, North Carolina, USA.
- ScitoVation, Durham, North Carolina, USA.
- Inotiv RTP, Morrisville, North Carolina, USA.
- Proctor & Gamble Co., Cincinnati, Ohio, USA.
- Charles River Laboratories, Illinois, USA.
- Toxys Inc., New York, New York, USA.
ORCID-Profile: Stefan Pfuhler, Bevin P Engelward
Förderung
- NIEHS NIH HHS
- SBIR 2B
- Charles River Laboratories
- Proctor and Gamble Co
- National Institute of Environmental Health Sciences
Zitieren
APA
Recio, L., Swartz, C., Martin, L., Rottinger, E., Pfuhler, S., Pinkus, E., Roberts, D. J., Stankowski, L. F., Kaushal, S., Owiti, N. A., & Engelward, B. P. (2025). Transferability and Reproducibility of the HepaRG CometChip Assay. Environmental and Molecular Mutagenesis. https://doi.org/10.1002/em.70037
Vancouver
Recio L, Swartz C, Martin L, Rottinger E, Pfuhler S, Pinkus E, et al. Transferability and Reproducibility of the HepaRG CometChip Assay. Environmental and Molecular Mutagenesis. 2025. doi:10.1002/em.70037
BibTeX
@article{Recio2025,
author = {Recio, Leslie and Swartz, Carol and Martin, Lincoln and Rottinger, Emily and Pfuhler, Stefan and Pinkus, Erica and Roberts, Daniel J and Stankowski, Leon F and Kaushal, Simran and Owiti, Norah A and Engelward, Bevin P},
title = {Transferability and Reproducibility of the HepaRG CometChip Assay},
journal = {Environmental and Molecular Mutagenesis},
year = {2025},
doi = {10.1002/em.70037}
}
EUVIMED